MLICM
AXSM icon

Metropolitan Life Insurance Company (MetLife)’s Axsome Therapeutics AXSM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,949
Closed -$156K – 233
2024
Q1 		$156K Sell
1,949
-93
-5% -$7.81K 0.01% 816
2023
Q4 		$163K Hold
2,042
– – 0.01% 838
2023
Q3 		$143K Buy
2,042
+264
+15% +$19.7K 0.01% 836
2023
Q2 		$128K Hold
1,778
– – 0.01% 890
2023
Q1 		$110K Sell
1,778
-203
-10% -$13.3K 0.01% 949
2022
Q4 		$153K Buy
1,981
+258
+15% +$15.4K 0.01% 836
2022
Q3 		$76.9K Sell
1,723
-186
-10% -$9.29K ﹤0.01% 1172
2022
Q2 		$73.1K Hold
1,909
– – ﹤0.01% 1257
2022
Q1 		$79K Sell
1,909
-6,439
-77% -$200K ﹤0.01% 1352
2021
Q4 		$315K Hold
8,348
– – ﹤0.01% 1714
2021
Q3 		$275K Hold
8,348
– – ﹤0.01% 1838
2021
Q2 		$563K Buy
8,348
+346
+4% +$20.8K 0.01% 1450
2021
Q1 		$453K Sell
8,002
-223
-3% -$15.7K 0.01% 1486
2020
Q4 		$670K Hold
8,225
– – 0.01% 1171
2020
Q3 		$586K Hold
8,225
– – 0.01% 1104
2020
Q2 		$677K Hold
8,225
– – 0.01% 1004
2020
Q1 		$484K Buy
8,225
+598
+8% +$48.7K 0.01% 1065
2019
Q4 		$788K Sell
7,627
-836
-10% -$33.8K 0.01% 1044
2019
Q3 		$171K Buy
8,463
+6,617
+358% +$170K ﹤0.01% 1988
2019
Q2 		$47.5K Buy
+1,846
New +$37K ﹤0.01% 2510

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AXSM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Axsome Therapeutics (AXSM) in Q2 2024, closing a stake of 1,949 shares — an estimated $156K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AXSM in Q2 2019 and held it in 20 quarters. The position peaked at $788K in Q4 2019. 257 funds tracked by Wall St. Rank hold AXSM as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Axsome Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,949 Axsome Therapeutics shares in Q2 2024, an estimated $156K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Axsome Therapeutics in Q2 2019 and held it in 20 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Axsome Therapeutics position peaked at $788K in Q4 2019.
  • 257 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.